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General remarks 
Column chromatography was performed on silica gel (Silica-P flash silica gel from Silicycle, size 40-63 μm). TLC 
was performed on silica gel 60/Kieselguhr F254. Components were visualized by UV and stained with a solution of 
a mixture of KMnO4 (10 g) and K2CO3 (10 g) in H2O (500 mL). Mass spectra were recorded on a AEI-MS-902 mass 
spectrometer (EI+) or a LTQ Orbitrap XL (ESI+). 1H and 13C NMR were recorded on a Varian AMX400 (400 and 
100.6 MHz, respectively) or a Varian Unity Plus Varian-500 (500 and 125 MHz, respectively) using CDCl3 as 
solvent. Chemical shift values are reported in ppm with the solvent resonance as the internal standard (CHCl3:  
7.26 for 1H,  77.0 for 13C; acetone:  2.05 for 1H,  29.8 ppm for 13C). Data are reported as follows: chemical shifts, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, br = broad, m = multiplet), coupling constants (Hz), and 
integration. Optical rotations were measured in CHCl3 on a Schmidt + Haensch polarimeter (Polartronic MH8) with 
a 10 cm cell (c given in g/100 mL). Conversions were determined by 1H NMR. Enantioselectivities were determined 
by HPLC analysis using a Shimadzu LC-10ADVP HPLC equipped with a Shimadzu SPD-M10AVP diode array 
detector or by capillary GC analysis. Melting points were determined on a Buchi B–545 melting point apparatus. All 
reactions were carried out under a nitrogen atmosphere using oven dried glassware and using standard Schlenk 
techniques. CH2Cl2 was dried and distilled over calcium hydride. THF and Et2O were dried and distilled over 
Na/benzophenone. [Ir(COD)Cl]2 was purchased from Strem Chemicals, Inc. Ligand L7 and L8 were prepared 
according to literature.1 
 




Representative procedure for the synthesis of allylic carbonate 1a. 
The amino alcohol S2a was prepared following a literature procedure. [2] A mixture of o-nitrocinnamyl alcohol 
S1a (1.7 g, 9.5 mmol) and FeSO4·7H2O (25.0 g, 90.9 mmol) in a mixture of methanol (100 mL) and conc. aqueous 
ammonium hydroxide (120 mL) was heated at 80 oC for 3 h. After cooling to room temperature, the mixture was 
extracted with DCM (6×50 mL). The combined organic solution was dried over Na2SO4 and the solvent evaporated. 
The residue was purified by chromatography (3 : 7 pentane–EtOAc) to give S2a (1.41 g, 95%) as a light brown solid. 
To a solution of S2a (1.49 g, 10 mmol) and Et3N (4.2 mL, 30 mmol) in dry CH2Cl2 (50 mL) was added dropwise 
benzoyl chloride (3.5 mL, 30 mmol) at 0 °C. The mixture was stirred at room temperature for 12 h. The solvent was 
removed under vacuum and the residue was dissolved in a mixture of THF (40 mL), MeOH (40 mL) and 1 N aq. 
NaOH (40 mL). The mixture was then stirred at room temperature for 2 h to hydrolyze the benzoic ester. After 
                                                     
[1] W.-B. Liu, C. Zheng, C.-X. Zhuo, L.-X. Dai, S.-L. You, J. Am. Chem. Soc., 2012, 134, 4812. 
[2] J. M. Cuerva, D. J. Cárdenas,  A. M. Echavarren,  J. Chem. Soc., Perkin Trans. 1, 2002, 1360. 
 
S2
extraction with CH2Cl2 (3 x 50 mL), the combined organic layers were washed with brine, dried over Na2SO4 and 
concentrated under vacuum.  The residue was purified by chromatography (1 : 1 pentane–EtOAc) to give S3a as 
light brown solid in 85% yield. 
 
To a solution of allyl alcohol S3a (1.68 g, 6.6 mmol) and pyridine (1.65 mL, 3 equiv) in CH2Cl2 (50 mL), methyl 
chloroformate (1.0 mL, 2 equiv) was added dropwise at 0 °C. The reaction mixture was allowed to warm to room 
temperature and subsequently stirred for 1 h. Upon completion, the reaction mixture was diluted  with CH2Cl2 (50 
mL)  and washed with aq. HCl (2N) (3 x 40 mL). The organic layer was dried over Na2SO4 and concentrated under 
vacuum. The residue was purified by chromatography (3 : 1 pentane–EtOAc) to give 1a as a light brown solid in 99% 
yield. 




1H NMR (400 MHz, CDCl3) δ = 7.25 (d, J = 8.2 Hz, 1H), 7.08 (td, J = 8.0, 1.4 Hz, 1H), 6.76 (t, J = 7.4 Hz, 1H), 
6.71 – 6.60 (m, 2H), 6.22 (dt, J = 15.7, 5.6 Hz, 1H), 4.30 (dd, J = 5.6, 1.5 Hz, 2H), 3.63 (brs, 2H). 




1H NMR (400 MHz, CDCl3) δ 7.94 (s, 1H), 7.89 (d, J = 7.2 Hz, 3H), 7.56 (t, J = 7.4 Hz, 1H), 7.49 (t, J = 7.4 Hz, 
2H), 7.43 (d, J = 7.7 Hz, 1H), 7.32 (td, J = 8.1, 1.3 Hz, 1H), 7.19 (t, J = 7.2 Hz, 1H), 6.73 (d, J = 15.8 Hz, 1H), 6.29 
(dt, J = 15.8, 5.3 Hz, 1H), 4.31 (dd, J = 5.3, 1.6 Hz, 2H), 2.11 (brs, 1H). 
13C NMR (101 MHz, CDCl3) δ 166.0, 134.6, 134.4, 132.9, 131.9, 130.1, 128.2, 128.4, 127.2, 127.1, 125.7, 125.5, 
124.1, 63.4. 
HRMS (ESI+, m/z) calculated for C16H16NO2 [M + H]+ 254.1176; found 254.1172. 
1a 
(E)-3-(2-Benzamidophenyl)allyl methyl carbonate (1a) 
1H NMR (400 MHz, CDCl3) δ = 7.97 (d, J = 8.1 Hz, 1H), 7.96 – 7.85 (m, 3H), 7.57 (t, J = 7.5 Hz, 1H), 7.57 – 7.45 
(m, 2H), 7.42 (d, J = 7.8, 1H), 7.34 (td, J = 7.6, 1.6 Hz, 1H), 7.18 (t, J = 7.5 Hz, 1H), 6.84 (d, J = 15.8 Hz, 1H), 6.22 
(dt, J = 15.8, 6.3 Hz, 1H), 4.79 (dd, J = 6.3, 1.4 Hz, 2H), 3.77 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 165.6, 155.6, 134.7, 134.5, 131.9, 130.0, 129.2, 128.9, 128.8, 127.3, 127.2, 126.9, 
125.5, 123.8, 68.1, 54.8. 
S3
HRMS (ESI+, m/z) calculated for C18H18NO4 [M + H]+ 312.1230; found 312.1229. 
 S2b 
(E)-3-(2-Amino-5-chlorophenyl)prop-2-en-1-ol (S2b) 
1H NMR (400 MHz, CDCl3) δ = 7.22 (d, J = 2.4 Hz, 1H), 7.02 (dd, J = 8.5, 2.4 Hz, 1H), 6.62 (s, 1H), 6.59 (d, J = 
5.7 Hz, 1H), 6.24 (dt, J = 15.7, 5.4 Hz, 1H), 4.34 (dd, J = 5.4, 1.6 Hz, 2H), 2.86 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 142.2, 131.5, 128.3, 127.0, 125.2, 124.5, 123.6, 117.2, 63.6. 
HRMS (ESI+, m/z) calculated for C9H11ClNO [M +H]+ 184.0524; found 184.0528. 
 S2c 
(E)-3-(2-Amino-4-bromophenyl)prop-2-en-1-ol (S2c) 
1H NMR (400 MHz, CDCl3) δ = 7.09 (d, J = 8.2 Hz, 1H), 6.86 (dd, J = 8.2, 1.9 Hz, 1H), 6.83 (d, J = 1.9 Hz, 1H), 
6.58 (d, J = 15.7 Hz, 1H), 6.22 (dt, J = 15.7, 5.5 Hz, 1H), 4.32 (dd, J = 5.5, 1.6 Hz, 2H). 
13C NMR (101 MHz, CDCl3) δ = 144.9, 130.9, 128.8, 125.5, 122.0, 121.9, 121.8, 118.5, 63.7. 
HRMS (ESI+, m/z) calculated for C9H11BrNO [M +H]+ 228.0019; found 228.0025. 
 
1b 
(E)-Methyl (3-(2-(4-methylbenzamido)phenyl)allyl) carbonate (1b) 
1H NMR (400 MHz, CDCl3) δ = 7.98 (d, J = 8.1 Hz, 1H), 7.82 (brs, 1H), 7.81 (d, J = 8.1 Hz, 2H), 7.42 (d, J = 7.7 
Hz, 1H), 7.34 (t, J = 7.8 Hz, 1H), 7.30 (d, J = 8.0 Hz, 2H), 7.18 (t, J = 7.2 Hz, 1H), 6.84 (d, J = 15.8 Hz, 1H), 6.22 
(dt, J = 15.8, 6.3 Hz, 1H), 4.79 (dd, J = 6.3, 1.2 Hz, 2H), 3.78 (s, 3H), 2.43 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 165.5, 155.6, 142.5, 134.9, 131.7, 130.1, 129.5, 129.1, 129.0, 127.3, 127.2, 126.9, 
125.4, 123.7, 68.2, 54.9, 21.5. 
HRMS (ESI+, m/z) calculated for C19H20NO4 [M + H]+ 326.1387; found 326.1385. 
1c 
S4
(E)-3-(2-(4-Methoxybenzamido)phenyl)allyl methyl carbonate (1c) 
1H NMR (400 MHz, CDCl3) δ = 7.95 (d, J = 8.0 Hz, 1H), 7.88 (d, J = 8.8 Hz, 2H), 7.82 (brs, 1H), 7.41 (d, J = 7.7 
Hz, 1H), 7.33 (t, J = 7.7 Hz, 1H), 7.16 (t, J = 7.5 Hz, 1H), 6.98 (d, J = 8.8 Hz, 2H), 6.84 (d, J = 15.8 Hz, 1H), 6.21 
(dt, J = 15.8, 6.3 Hz, 1H), 4.78 (dd, J = 6.3, 1.2 Hz, 2H), 3.87 (s, 3H), 3.78 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 165.1, 162.6, 155.6, 135.0, 130.2, 129.09, 129.06, 128.9, 127.3, 126.7, 126.7, 125.3, 
123.8, 114.0, 68.2, 55.4, 54.8. 
HRMS (ESI+, m/z) calculated for C19H20NO5 [M + H]+ 342.1336; found 342.1333. 
1d 
(E)-3-(2-(4-(tert-butyl)benzamido)phenyl)allyl methyl carbonate (1d) 
1H NMR (400 MHz, CDCl3) δ = 7.97 (d, J = 8.0 Hz, 1H), 7.89 (brs, 1H), 7.86 (d, J = 8.1 Hz, 2H), 7.52 (d, J = 8.0 
Hz, 2H), 7.41 (d, J = 7.6 Hz, 1H), 7.33 (t, J = 7.6 Hz, 1H), 7.17 (t, J = 7.4 Hz, 1H), 6.84 (d, J = 15.8 Hz, 1H), 6.22 
(dt, J = 12.9, 6.1 Hz, 1H), 4.79 (d, J = 6.1 Hz, 2H), 3.78 (s, 3H), 1.36 (s, 9H). 
13C NMR (101 MHz, CDCl3) δ = 165.5, 162.6, 155.5, 134.9, 131.6, 130.1, 129.1, 128.9, 127.3, 127.0, 126.8, 125.73, 
125.4, 123.8, 68.2, 54.8, 35.0, 31.1. 
HRMS (ESI+, m/z) calculated for C22H26NO4 [M + H]+ 368.1856; found 368.1852. 
1e 
(E)-3-(2-(Furan-2-carboxamido)phenyl)allyl methyl carbonate (1e) 
1H NMR (400 MHz, CDCl3) δ = 8.11 (brs, 1H), 8.00 (d, J = 8.1 Hz, 1H), 7.54 (s, 1H), 7.42 (d, J = 7.7 Hz, 1H), 7.33 
(t, J = 7.4 Hz, 1H), 7.25 (d, J = 3.5 Hz, 1H), 7.17 (t, J = 7.6 Hz, 1H), 6.84 (d, J = 15.8 Hz, 1H), 6.57 (dd, J = 3.3, 
1.6 Hz, 1H), 6.26 (dt, J = 15.8, 6.3 Hz, 1H), 4.82 (d, J = 6.3 Hz, 2H), 3.80 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 156.1, 155.5, 147.7, 144.4, 134.0, 129.6, 128.9, 128.7, 127.4, 126.9, 125.4, 123.4, 
115.4, 112.6, 68.2, 54.9. 
HRMS (ESI+, m/z) calculated for C16H16NO5 [M + H]+ 302.1023; found 302.1024. 
1f 
S5
(E)-Methyl (3-(2-(thiophene-2-carboxamido)phenyl)allyl) carbonate (1f) 
1H NMR (400 MHz, CDCl3) δ 7.90 (d, J = 8.0 Hz, 1H), 7.83 (brs, 1H), 7.68 (d, J = 3.4 Hz, 1H), 7.55 (dd, J = 5.0, 
0.8 Hz, 1H), 7.40 (d, J = 7.7 Hz, 1H), 7.31 (t, J = 7.7 Hz, 1H), 7.17 (t, J = 7.4 Hz, 1H), 7.12 (dd, J = 4.9, 3.8 Hz, 1H), 
6.83 (d, J = 15.8 Hz, 1H), 6.20 (dt, J = 15.8, 6.3 Hz, 1H), 4.78 (dd, J = 6.3, 1.2 Hz, 2H), 3.78 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 160.0, 155.6, 139.0, 134.4, 130.9, 130.1, 129.1, 128.9, 128.6, 127.8, 127.3, 126.8, 
125.6, 123.9, 68.1, 54.8. 
HRMS (ESI+, m/z) calculated for C16H16NO5 [M + H]+ 318.0795; found 318.0796. 
1g 
(E)-Methyl (3-(2-(4-nitrobenzamido)phenyl)allyl) carbonate (1g) 
1H NMR (400 MHz, acetone) δ 9.65 (s, 1H), 8.42 (d, J = 8.8 Hz, 2H), 8.32 (d, J = 8.7 Hz, 2H), 7.70 (d, J = 7.7 Hz, 
1H), 7.65 (d, J = 7.8 Hz, 1H), 7.40 (td, J = 7.7, 1.3 Hz, 1H), 7.33 (t, J = 7.2 Hz, 1H), 7.06 (d, J = 15.9 Hz, 1H), 6.39 
(dt, J = 15.8, 6.3 Hz, 1H), 4.79 (dd, J = 6.3, 1.2 Hz, 2H), 3.76 (s, 3H). 
13C NMR (101 MHz, acetone) δ = 165.9, 157.1, 151.4, 142.3, 136.8, 133.6, 131.3, 130.7, 130.0, 128.4, 128.2, 128.0, 
126.9, 125.1, 69.5, 55.8. 
HRMS (ESI+, m/z) calculated for C18H17N2O6 [M + H]+ 357.1081; found 357.1078. 
1h 
(E)-3-(2-(4-Bromobenzamido)phenyl)allyl methyl carbonate (1h) 
1H NMR (400 MHz, CDCl3) δ = 7.96 (d, J = 8.1 Hz, 1H), 7.84 (brs, 1H), 7.79 (d, J = 8.4 Hz, 2H), 7.64 (d, J = 8.4 
Hz, 2H), 7.41 (d, J = 7.7 Hz, 1H), 7.35 (t, J = 7.8 Hz, 1H), 7.19 (t, J = 7.6 Hz, 1H), 6.82 (d, J = 15.8 Hz, 1H), 6.20 
(dt, J = 15.8, 6.3 Hz, 1H), 4.79 (dd, J = 6.3, 0.9 Hz, 2H), 3.78 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 164.7, 155.6, 134.5, 133.3, 132.0, 130.1, 129.2, 129.0, 128.8, 127.4, 127.2, 126.7, 
125.7, 123.7, 68.1, 54.9. 
HRMS (ESI+, m/z) calculated for C16H13BrNO [M -OCOOMe]+ 314.0175; found 314.0178. 
S6
1i 
(E)-3-(2-(4-Chlorobenzamido)phenyl)allyl methyl carbonate (1i) 
1H NMR (400 MHz, CDCl3) δ 7.93 (d, J = 8.1 Hz, 1H), 7.88 (brs, 1H), 7.85 (d, J = 8.5 Hz, 2H), 7.46 (d, J = 8.5 Hz, 
2H), 7.41 (d, J = 7.7 Hz, 1H), 7.34 (dd, J = 11.1, 4.4 Hz, 1H), 7.19 (t, J = 7.5 Hz, 1H), 6.82 (d, J = 15.8 Hz, 1H), 
6.20 (dt, J = 15.8, 6.3 Hz, 1H), 4.78 (dd, J = 6.3, 1.1 Hz, 2H), 3.78 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 164.6, 155.6, 138.2, 134.5, 132.8, 130.1, 129.3, 129.0, 129.0, 128.7, 127.3, 127.1, 
125.7, 123.8, 68.1, 54.9. 
HRMS (ESI+, m/z) calculated for C16H13ClNO [M -OCOOMe]+ 270.0680; found 270.0682. 
1j 
(E)-3-(2-(3-Chlorobenzamido)phenyl)allyl methyl carbonate (1j) 
1H NMR (201 MHz, CDCl3) δ 8.02 – 7.83 (m, 3H), 7.78 (d, J = 7.6 Hz, 1H), 7.61 – 7.27 (m, 4H), 7.20 (t, J = 7.5 Hz, 
1H), 6.83 (d, J = 15.8 Hz, 1H), 6.20 (dt, J = 15.8, 6.3 Hz, 1H), 4.78 (d, J = 6.2 Hz, 3H), 3.77 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 164.7, 155.4, 134.8, 134.2, 131.7, 130.5, 130.4, 130.3, 129.6, 129.4, 128.8, 127.3, 
127.0, 126.6, 125.9, 124.2, 68.0, 54.8. 
HRMS (ESI+, m/z) calculated for C18H17ClNO4 [M +H]+ 346.0841; found 346.0837. 
1k 
(E)-3-(2-(2-chlorobenzamido)phenyl)allyl methyl carbonate (1k) 
1H NMR (400 MHz, CDCl3) δ = 7.96 (d, J = 7.7 Hz, 1H), 7.90 (s, 1H), 7.82 (d, J = 5.1 Hz, 1H), 7.53 – 7.30 (m, 5H), 
7.21 (t, J = 7.2 Hz, 1H), 6.91 (d, J = 15.6 Hz, 1H), 6.23 (dt, J = 15.5, 5.9 Hz, 1H), 4.79 (d, J = 5.8 Hz, 2H), 3.77 (s, 
3H). 
13C NMR (101 MHz, CDCl3) δ = 164.5, 155.5, 136.2, 134.9, 134.3, 131.9, 129.99, 129.96, 129.7, 128.9, 127.6, 127.2, 
126.7, 125.9, 125.2, 124.3, 68.1, 54.8. 
S7
HRMS (ESI+, m/z) calculated for C18H17ClNO4 [M +H]+ 346.0841; found 346.0836. 
1l 
(E)-3-(2-Benzamido-5-chlorophenyl)allyl methyl carbonate (1l) 
1H NMR (400 MHz, CDCl3) δ = 7.97 – 7.82 (m, 4H), 7.57 (t, J = 7.4 Hz, 1H), 7.49 (t, J = 7.4 Hz, 2H), 7.38 (d, J = 
2.4 Hz, 1H), 7.27 (dd, J = 8.6, 2.5 Hz, 1H), 6.75 (d, J = 15.8 Hz, 1H), 6.20 (dt, J = 15.7, 6.1 Hz, 1H), 4.76 (dd, J = 
6.1, 1.4 Hz, 2H), 3.76 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 165.6, 155.5, 134.1, 133.3, 132.1, 130.9, 130.8, 128.8, 128.7, 128.6, 128.0, 127.2, 
127.0, 125.2, 67.7, 54.9. 




(E)-3-(2-Benzamido-4-bromophenyl)allyl methyl carbonate (1m) 
1H NMR (400 MHz, CDCl3) δ = 8.25 (s, 1H), 8.00 – 7.81 (m, 3H), 7.58 (t, J = 7.4 Hz, 1H), 7.50 (t, J = 7.3 Hz, 2H), 
7.34 – 7.20 (m, 2H), 6.75 (d, J = 15.8 Hz, 1H), 6.20 (dt, J = 15.8, 6.2 Hz, 1H), 4.77 (dd, J = 6.1, 1.4 Hz, 2H), 3.77 
(s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 165.4, 155.5, 135.8, 134.0, 132.2, 129.0, 128.9, 128.5, 128.4, 127.7, 127.7, 127.2, 
126.3, 125.5, 122.4, 67.9, 54.9. 
HRMS (ESI+, m/z) calculated for C18H17BrNO4 [M +H]+ 390.0335; found 390.0340. 
1n 
(E)-Methyl (3-(2-pivalamidophenyl)allyl) carbonate (1n) 
1H NMR (400 MHz, CDCl3) δ = 7.83 (d, J = 8.1 Hz, 1H), 7.40 – 7.32 (m, 2H), 7.34 – 7.23 (m, 1H), 7.12 (d, J = 
15.1 Hz, 1H), 6.72 (d, J = 15.7, 1H), 6.17 (dt, J = 15.8, 6.2 Hz, 1H), 4.78 (dd, J = 6.2, 1.4 Hz, 2H), 3.79 (s, 2H), 
3.44 (s, 3H), 1.32 (s, 9H). 
S8
13C NMR (101 MHz, CDCl3) δ = 176.6, 155.5, 134.8, 129.7, 129.0, 128.8, 127.1, 126.6, 125.1, 123.7, 68.0, 54.8, 
39.6, 27.6. 
HRMS (ESI+, m/z) calculated for C16H22NO4 [M +H]+ 292.1543; found 292.1553. 
 
General procedure for the synthesis of allylic carbonate 1o and 1p. 
 
 
To a solution of S4 (15.0 mmol) 3  and S5 (Z)-but-2-ene-1,4-diyl dimethyl dicarbonate (30.0 mmol) in dry 
dichloromethane (50 mL), HG-II catalyst (5 mol%) was added and the mixture was heated at reflux for 2-3 h. After  
cooling down to room temperature, the solvent was removed under reduced pressure to yield the crude product 
which was purified by silica gel chromatography (EtOAc/Pentane 1:2) affording the pure compounds (1o, 76% yield; 
1p, 81% yield). 
 
1o 
(E)-4-benzamidobut-2-en-1-yl methyl carbonate (1o) 
1H NMR (400 MHz, CDCl3) δ = 7.77 (d, J = 7.4 Hz, 2H), 7.51 (t, J = 7.3 Hz, 1H), 7.43 (t, J = 7.5 Hz, 2H), 6.21 (brs, 
1H), 5.93 (dt, J = 15.4, 5.5 Hz, 1H), 5.81 (dt, J = 11.4, 6.0 Hz, 1H), 4.63 (d, J = 5.8 Hz, 2H), 4.18 – 4.06 (m, 2H), 
3.79 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 167.3, 155.4, 134.1, 131. 5, 131.4, 128.4, 127.1, 126.9, 125.4, 67.4, 54.7, 41.0. 
HRMS (ESI+, m/z) calculated for C13H15NO4Na [M +Na]+ 272.0893; found 272.0896. 
 
1p 
(E)-5-benzamidopent-2-en-1-yl methyl carbonate (1p) 
1H NMR (400 MHz, CDCl3) δ 7.73 (d, J = 7.2 Hz, 2H), 7.48 (t, J = 7.3 Hz, 1H), 7.40 (t, J = 7.4 Hz, 2H), 6.31 (brs, 
1H), 5.82 (dt, J = 15.5, 7.3 Hz, 1H), 5.69 (dt, J = 15.5, 6.1 Hz, 1H), 4.58 (d, J = 5.9 Hz, 2H), 3.75 (s, 3H), 3.52 (q, J 
= 6.5 Hz, 2H), 2.38 (q, J = 6.6 Hz, 2H). 
13C NMR (101 MHz, CDCl3) δ 170.0, 158.1, 137.2, 135.7 133.9, 131.1, 129.4, 128.8, 70.6, 57.3, 41.4, 34.9. 
HRMS (ESI+, m/z) calculated for C14H17NO4Na [M +Na]+ 286.1050; found 286.1053. 
                                                     
[3] S4 were prepared according to literature procedures: a) X. Zhang, B. Cao, S. Yu, X. Zhang, Angew. Chem. Int. 
Ed. 2010, 49, 4047; b) S. Mizuta, S. Verhoog, K. M. Engle, T. Khotavivattana, M. O’Duill, K. Wheelhouse, G. 
Rassias, M. Médebielle,  V. Gouverneur,  J. Am. Chem. Soc. 2013, 135, 2505. 
S9
 General Procedure for the Iridium-catalyzed asymmetric allylic cyclization of 1a to 1n: 
 
 
To a suspension of [Ir(COD)Cl]2 (3.3 mg, 2.5 mol%) and L7 (4.47 mg, 5.0 mol%) in 2 mL dry THF was added  3.0 
eq. DABCO (72.6 mg, 0.6 mmol) under a N2 atmosphere. Then the reaction mixture was heated at 50 °C for 30 min 
to generate the catalyst. The corresponding allylic carbonate (2 mmol) was added and the reaction mixture was 
stirred until TLC showed full conversion. All volatiles were removed under reduced pressure and the residue was 




Synthesized according to general procedure; 81% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiracel OD-H), n-heptane/i-propanol = 90:10, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (major) 8.64 min, tR 
(minor) 9.32 min, ee = 97%; [α]20D = -8.2 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 8.22 – 8.13 (m, 2H), 7.55 – 7.40 (m, 3H), 7.38 – 7.31 (m, 2H), 7.24 – 7.18 (m, 1H), 
7.04 (d, J = 6.5 Hz, 1H), 6.11 (ddd, J = 17.4, 10.1, 6.4 Hz, 1H), 5.88 (d, J = 1.3 Hz, 1H), 5.35 (d, J = 6.2 Hz, 1H), 
5.31 (d, J = 1.2 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ = 156.6, 139.1, 135.5, 132.5, 131.4, 129.1, 128.2, 128.0, 126.5, 125.0, 124.5, 124.1, 
118.4, 77.2. 





Synthesized according to general procedure; 93% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiralpak OB-H), n-heptane/i-propanol = 90:10, 40 °C, 254 nm,  0.5 mL/min, retention times: tR (minor) 12.42 min, 
tR (major) 36.83 min, ee = 94%; [α]20D = -18.8 (c 1.0, CHCl3). 
S10
1H NMR (400 MHz, CDCl3) δ = 8.07 (d, J = 8.2 Hz, 2H), 7.39 – 7.28 (m, 2H), 7.29 – 7.23 (m, 2H), 7.19 (ddd, J = 
7.5, 5.9, 2.8 Hz, 1H), 7.04 (d, J = 7.1 Hz, 3H), 6.10 (ddd, J = 16.8, 10.3, 6.3 Hz, 1H), 5.86 (d, J = 1.3 Hz, 1H), 5.34 
(d, J = 7.7 Hz, 1H), 5.31 (d, J = 1.2 Hz, 1H), 2.42 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 156.7, 141.8, 139.2, 135.5, 129.7, 129.0, 129.0, 128.0, 126.2, 124.8, 124.4, 124.1, 
118.2, 77.3, 77.1, 77.0, 76.7, 21.6. 







Synthesized according to general procedure; 92% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiralpak AS-H), n-heptane/i-propanol = 95:5, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (major) 9.43 min, tR 
(minor) 12.34 min, ee = 95%; [α]20D = -30.8 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 8.12 (d, J = 8.9 Hz, 2H), 7.37 – 7.27 (m, 2H), 7.22 – 7.14 (m, 1H), 7.03 (d, J = 7.4 
Hz, 1H), 6.95 (d, J = 8.9 Hz, 2H), 6.16 – 5.98 (m, 1H), 5.84 (d, J = 1.3 Hz, 1H), 5.34 (d, J = 6.8 Hz, 1H), 5.30 (d, J 
= 1.1 Hz, 1H), 3.86 (s, 3H). 
13C NMR (101 MHz, CDCl3) δ = 162.3, 156.5, 139.4, 135.5, 129.8, 129.0, 126.0, 124.9, 124.6, 124.4, 124.1, 118.2, 
113.6, 77.1, 55.4. 




Synthesized according to general procedure; 81% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiralpak OJ-H), n-heptane/i-propanol = 95:5, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (major) 11.68 min, 
tR (minor) 15.36 min, ee = 96%; [α]20D = -20.0 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 8.10 (d, J = 8.5 Hz, 2H), 7.47 (d, J = 8.5 Hz, 2H), 7.37 – 7.29 (m, 2H), 7.19 (ddd, J 
= 7.6, 5.2, 3.4 Hz, 1H), 7.04 (d, J = 7.9 Hz, 1H), 6.10 (ddd, J = 16.8, 10.3, 6.3 Hz, 1H), 5.85 (d, J = 6.2 Hz, 1H), 
5.34 (d, J = 9.7 Hz, 1H), 5.32 – 5.28 (m, 1H), 1.36 (s, 9H). 
S11
13C NMR (101 MHz, CDCl3) δ = 31.2, 34.9, 77.1, 118.2, 124.2, 124.4, 124.9, 125.2, 126.2, 127.8, 129.0, 129.7, 
135.5, 139.3, 154.9, 156.7. 




Synthesized according to general procedure; 87% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiralpak OB-H), n-heptane/i-propanol = 90:10, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (minor) 17.31 min, 
tR (major) 26.39 min, ee = 97%; [α]20D = -3.8 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.59 (s, 1H), 7.39 – 7.26 (m, 2H), 7.18 (td, J = 7.3, 1.5 Hz, 1H), 7.09 (d, J = 3.4 Hz, 
1H), 7.00 (d, J = 7.7 Hz, 1H), 6.51 (dd, J = 3.5, 1.7 Hz, 1H), 6.06 (ddd, J = 16.3, 10.8, 6.3 Hz, 1H), 5.80 (d, J = 6.4 
Hz, 1H), 5.34 (d, J = 1.1 Hz, 1H), 5.31 (d, J = 7.0 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ = 149.5, 146.5, 145.6, 138.4, 135.0, 129.2, 126.5, 125.0, 124.5, 124.0, 118.7, 114.8, 
111.8, 77.2. 




Synthesized according to general procedure; 83% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiracel OD-H), n-heptane/i-propanol = 95:5, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (major) 10.37 min, tR 
(minor) 14.00 min, ee = 95%; [α]20D = -21.6 (c 1.01, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.79 – 7.73 (m, 1H), 7.49 (dd, J = 5.1, 1.2 Hz, 1H), 7.37 – 7.26 (m, 2H), 7.18 (td, J 
= 7.2, 1.8 Hz, 1H), 7.10 (dd, J = 5.0, 3.7 Hz, 1H), 7.02 (d, J = 7.8 Hz, 1H), 6.08 (ddd, J = 16.8, 10.1, 6.2 Hz, 1H), 
5.83 (d, J = 6.2 Hz, 1H), 5.35 (d, J = 3.8 Hz, 1H), 5.32 (d, J = 3.5 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ = 155.3, 138.7, 135.2, 134.4, 134.3, 131.3, 129.5, 129.2, 128.0, 126.8, 126.0, 125.1, 
124.5, 124.0, 118.7, 77.4. 





Synthesized according to general procedure; 93% yield; yellow solid, m.p. = 147-149 oC; enantiomeric excess was 
determined by HPLC (Chiralpak AS-H), n-heptane/i-propanol = 95:5, 40 °C, 254 nm, 0.5 mL/min, retention times: 
tR (major) 14.73 min, tR (minor) 17.73 min, ee = 92%; [α]20D = -18.6 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 8.32 (d, J = 8.9 Hz, 2H), 8.26 (d, J = 8.8 Hz, 2H), 7.41 – 7.30 (m, 2H), 7.25 (td, J 
= 6.9, 1.8 Hz, 1H), 7.05 (d, J = 7.4 Hz, 1H), 6.09 (ddd, J = 16.9, 10.3, 6.5 Hz, 1H), 5.91 (d, J = 6.5 Hz, 1H), 5.40 – 
5.29 (m, 2H). 
13C NMR (101 MHz, CDCl3) δ = 154.3, 149.4, 138.4, 138.3, 135.1, 129.3, 128.7, 127.5, 125.4, 124.6, 123.8, 123.4, 
119.0, 77.6. 




Synthesized according to general procedure; 90% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiralpak OJ-H), n-heptane/i-propanol = 90:10, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (major) 14.67 min, 
tR (minor) 17.55 min, ee = 97%; [α]20D = -18.4 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 8.03 (d, J = 8.6 Hz, 2H), 7.57 (d, J = 8.6 Hz, 2H), 7.38 – 7.28 (m, 2H), 7.21 (td, J 
= 7.1, 1.9 Hz, 1H), 7.04 (d, J = 7.5 Hz, 1H), 6.08 (ddd, J = 16.9, 10.4, 6.4 Hz, 1H), 5.86 (d, J = 6.4 Hz, 1H), 5.34 (d, 
J = 3.6 Hz, 1H), 5.31 (d, J = 10.3 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ = 155.7, 138.8, 135.3, 131.5, 129.5, 129.2, 126.7, 126.2, 125.0, 124.5, 124.0, 118.6, 
77.3. (One resonance is missing due to coincidental overlap) 





Synthesized according to general procedure; 90% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiralpak OJ-H), n-heptane/i-propanol = 90:10, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (major) 15.29 min, 
tR (minor) 19.18 min, ee = 95%; [α]20D  = -3.8 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 8.11 (d, J = 8.6 Hz, 2H), 7.41 (d, J = 8.6 Hz, 2H), 7.37 – 7.28 (m, 2H), 7.21 (td, J 
= 7.2, 1.9 Hz, 1H), 7.04 (d, J = 7.9 Hz, 1H), 6.09 (ddd, J = 16.9, 10.4, 6.4 Hz, 1H), 5.85 (d, J = 6.4 Hz, 1H), 5.34 
(dd, J = 2.0, 1.2 Hz, 1H), 5.31 (d, J = 9.6 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ = 155.6, 138.8, 137.6, 135.3, 134.7, 131.0, 129.3, 129.2, 128.5, 126.7, 125.0, 124.5, 
124.0, 118.5, 77.3. 




Synthesized according to general procedure; 67% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiralpak OJ-H), n-heptane/i-propanol = 95:5, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (major) 12.85 min, tR 
(minor) 17.61 min, ee = 83%; [α]20D  = -2.0 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 8.15 (s, 1H), 8.05 (d, J = 7.8 Hz, 1H), 7.46 (ddd, J = 8.0, 2.1, 1.1 Hz, 1H), 7.41 – 
7.29 (m, 3H), 7.22 (ddd, J = 7.5, 6.4, 2.2 Hz, 1H), 7.04 (d, J = 7.3 Hz, 1H), 6.09 (ddd, J = 16.9, 10.4, 6.4 Hz, 1H), 
5.87 (d, J = 6.2 Hz, 1H), 5.35 (d, J = 5.1 Hz, 1H), 5.32 (d, J = 11.8 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ = 155.3, 138.7, 135.2, 134.4, 134.3, 131.3, 129.5, 129.2, 128.0, 126.8, 126.0, 125.1, 
124.5, 124.0, 118.7, 77.4. 





Synthesized according to general procedure; 67% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiracel OD-H), n-heptane/i-propanol = 95:5, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (major) 10.54 min, tR 
(minor) 15.32 min, ee = 97%; [α]20D  = +6.0 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.74 (dd, J = 7.5, 1.9 Hz, 1H), 7.44 (dd, J = 7.9, 1.4 Hz, 1H), 7.41 – 7.29 (m, 4H), 
7.28 – 7.21 (m, 1H), 7.04 (d, J = 7.4 Hz, 1H), 6.21 (ddd, J = 17.2, 10.3, 7.1 Hz, 1H), 5.92 (d, J = 7.2 Hz, 1H), 5.41 
(d, J = 4.5 Hz, 1H), 5.38 (d, J = 11.3 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ = 157.2, 138.7, 135.0, 133.3, 132.7, 131.3, 131.1, 130.5, 129.2, 127.1, 126.7, 125.0, 
124.5, 123.8, 119.6, 78.1. 




Synthesized according to general procedure; 89% yield; yellow oil; enantiomeric excess was determined by HPLC 
(Chiralpak OB-H), n-heptane/i-propanol = 98:2, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (minor) 18.33 min, 
tR (major) 21.89, ee= 90%; [α]20D  = -4.4 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 8.15 (d, J = 7.0 Hz, 2H), 7.51 (t, J = 7.2 Hz, 1H), 7.44 (t, J = 7.3 Hz, 2H), 7.34 – 
7.21 (m, 2H), 7.03 (d, J = 2.2 Hz, 1H), 6.07 (ddd, J = 16.9, 10.6, 6.5 Hz, 1H), 5.81 (d, J = 6.5 Hz, 1H), 5.39 (s, 1H), 
5.35 (d, J = 7.6 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ = 156.8, 137.8, 134.7, 132.1, 131.6, 131.4, 129.1, 128.3, 128.0, 126.2, 125.6, 124.6, 
119.1, 77.3, 77.0, 76.8, 76.7. 




Synthesized according to general procedure; 81% yield; colorless solid, m.p. = 74-76 oC; enantiomeric excess was 
determined by HPLC (Chiralpak OJ-H), n-heptane/i-propanol = 95:5, 40 °C, 254 nm, 0.5 mL/min, retention times: 
tR (major) 18.40 min, tR (minor) 23.22 min, ee = 93%; [α]20D = -11.4 (c 1.0, CHCl3). The absolute configuration of 2m 
was determined as R by X-ray crystallographic analysis.[4] 
                                                     
[4] CCDC 957091 contains the supplementary crystallographic data for 2m. 
S15
1H NMR (400 MHz, CDCl3) δ = 8.15 (d, J = 7.0 Hz, 2H), 7.57 – 7.40 (m, 4H), 7.32 (dd, J = 8.0, 2.0 Hz, 1H), 6.90 
(d, J = 8.0 Hz, 1H), 6.06 (ddd, J = 16.9, 10.4, 6.4 Hz, 1H), 5.82 (d, J = 6.4 Hz, 1H), 5.39 – 5.35 (m, 1H), 5.32 (d, J 
= 9.8 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ = 157.5, 140.7, 134.9, 132.1, 131.8, 129.2, 128.3, 128.3, 128.1, 127.9, 125.9, 123.0, 
122.4, 118.9, 77.0. 




Synthesized according to general procedure; 63% yield; yellow oil; enantiomeric excess was determined by Chiralsil 
Dex CB (25 m x 0.25 mm x 0.25 um), (initial temp. 40 °C, gradient 10 °C/min to 120 °C), retention time: tR (minor) 
35.48 min, tR (major) 35.93 min, ee = 86%; [α]20D = +41.8 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ = 7.31 – 7.23 (m, 1H), 7.19 (d, J = 7.7 Hz, 1H), 7.14 (td, J = 7.4, 1.3 Hz, 1H), 6.95 
(d, J = 7.5 Hz, 1H), 6.03 (ddd, J = 17.0, 10.3, 6.7 Hz, 1H), 5.63 (d, J = 6.7 Hz, 1H), 5.28 (d, J = 10.2 Hz, 1H), 5.22 
(d, J = 17.1 Hz, 1H), 1.26 (s, 9H). 
13C NMR (101 MHz, CDCl3) δ = 167.9, 138.9, 135.6, 128.9, 126.0, 124.6, 124.5, 123.7, 118.4, 76.7, 37.3, 27.6. 
HRMS (ESI+, m/z) calculated for C14H18NO [M + H]+ 216.1383; found 216.1388. 
 
General Procedure for the Iridium-catalyzed asymmetric allylic cyclization of 1o and 1p: 
 
 
To a suspension of [Ir(COD)Cl]2 (3.3 mg, 2.5 mol%) and L7 (4.47 mg, 5.0 mol%) in 2.0 mL dry THF was added  
0.5 eq. DBU (8 μL, 0.1 mmol) under a N2 atmosphere. Then the reaction mixture was heated at 50 °C for 30 min to 
generate the catalyst. After cooling down to room temperature, the corresponding allylic carbonate (0.2 mmol) was 
added and the reaction mixture was stirred at rt for 24 h until TLC showed full conversion. The reaction was 
quenched by H2O and extracted with ether. The combined organic layer was dried over Na2SO4 and concentrated 
under vacuum.  The residue was purified by silica gel column chromatography (Pentane/EtOAc = 10:1 to 4:1) to 





Synthesized according to general procedure; 60% yield; pale yellow oil; enantiomeric excess was determined by 
HPLC (Chiracel OD-H), n-heptane/i-propanol = 90:10, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (minor) 9.9 
min, tR (major) 18.5 min, ee = 95%; [α]20D  = -56.0 (c 1.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.96 (d, J = 7.3 Hz, 2H), 7.47 (t, J = 7.3 Hz, 1H), 7.41 (t, J = 7.4 Hz, 2H), 5.96 (ddd, 
J = 17.2, 10.3, 6.9 Hz, 1H), 5.38 (d, J = 17.1 Hz, 1H), 5.25 (d, J = 10.4 Hz, 1H), 5.18 – 5.02 (m,1H), 4.21 (dd, J = 
14.6, 9.9 Hz, 1H), 3.78 (dd, J = 14.6, 7.9 Hz, 1H). 
13C NMR (101 MHz, CDCl3) δ 163.9, 136.3, 131.3, 128.3, 128.2, 127.6, 117.3, 80.5, 60.4. 




Synthesized according to general procedure; 67% yield; pale yellow oil; enantiomeric excess was determined by 
HPLC (Chiracel OD-H), n-heptane/i-propanol = 90:10, 40 °C, 254 nm, 1.0 mL/min, retention times: tR (minor) 4.6 
min, tR (major) 6.3 min, ee = 92%; [α]20D  = +25.1 (c 2.0, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 7.88 (d, J = 6.8 Hz, 2H), 7.42 – 7.23 (m, 3H), 5.89 (ddd, J = 17.2, 10.6, 5.3 Hz, 1H), 
5.32 (dt, J = 17.2, 1.3 Hz, 1H), 5.21 (dt, J = 10.6, 1.2 Hz, 1H), 4.79 – 4.65 (m, 1H), 3.64 – 3.47 (m, 2H), 1.98 (dq, J 
= 13.3, 4.7, 1H), 1.72 (dtd, J = 14.1, 8.6, 5.7, 1H). 
13C NMR (101 MHz, CDCl3) δ 155.4, 136.6, 133.8, 130.4, 128.0, 126.9, 116.3, 74.9, 41.9, 26.9. 























2a 3  
To a solution of 2a (0.2 mmol, 47.5 mg) and ethyl acrylate (0.6 mmol, 64 μL) in dry dichloromethane (2 mL), HG-II 
catalyst (6.3 mg, 0.01 mmol, 5 mol%) was added and the mixture was heated at reflux for 18 h. The mixture was 
cooled down to room temperature and the solvent was removed under reduced pressure to yield the crude product 
which was purified by silica gel chromatography (EtOAc/Pentane 1:10) affording 3 in 70 % yield as colorless oil. 
Enantiomeric excess was determined by HPLC (Chiralpak AD-H), n-heptane/i-propanol = 90:10, 40 °C, 254 nm, 
0.5 mL/min, retention times: tR (minor) 11.16 min, tR (major) 12.07 min, ee = 90%; [α]20D = -85.6 (c 1.0, CHCl3). 1H 
NMR (400 MHz, CDCl3) δ = 8.18 (d, J = 8.4 Hz, 2H), 7.55 – 7.50 (m, 1H), 7.49 – 7.43 (m, 2H), 7.40 – 7.31 (m, 
2H), 7.25 – 7.19 (m, 1H), 7.12 – 7.01 (m, 2H), 6.06 (d, J = 5.4 Hz, 1H), 5.99 (d, J = 15.7 Hz, 1H), 4.17 (q, J = 7.1 
Hz, 2H), 1.25 (t, J = 7.1 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 165.7, 155.8, 143.4, 138.7, 132.0, 131.7, 129.6, 
128.4, 128.3, 128.0, 126.8, 125.4, 124.4, 122.7, 122.4, 74.9, 60.8, 14.1. HRMS (ESI+, m/z) calculated for 
C19H18NO3 [M + H]+ 308.1282; found 308.1281. 
 
Procedure for the addition of organolithium reagent to benzoxazine. 
 
 
General procedure for the addition of organolithium reagents to benzoxazine: To a solution of the 2a (40 mg, 0.17 
mmol) in THF (2 mL) was added the corresponding organolithium reagent at -78 °C (-40 °C for MeLi·LiBr). The 
mixture was allowed to gradually warm to RT (0 °C for MeLi·LiBr). After the reaction is completed as monitored 
by TLC, the reaction was quenched with water (2 ml) and the mixture extracted with CH2Cl2 (3 x 5 mL). The 
combined organic layers were dried over Na2SO4 and concentrated under vacuum. The residue was purified by silica 




Synthesized according to the general procedure for the addition of organolithium reagents to benzoxazine. 2a was 
treated with 1.5 eq of MeLi·LiBr and the mixture was allowed to gradually warm to 0 °C in 3 h. The product was 
obtained in 67% yield as white solid, m.p. = 122-124 °C. Enantiomeric excess was determined by HPLC (Chiralpak 
OJ-H), n-heptane/i-propanol = 90:10, 40 °C, 254 nm, 0.5 mL/min, retention times: tR (minor) 13.0 min, tR (major) 
17.0 min, ee = 96%; [α]20D = +200.0 (c 1.04, CHCl3). The relative configuration of 4a was determined by X-ray 
analysis[5] and NOESY experiment. 1H NMR (500 MHz, CDCl3) δ = 7.54 (d, J = 7.3 Hz, 2H), 7.32 (t, J = 7.5 Hz, 
2H), 7.26 (t, J = 7.3 Hz, 1H), 7.12 (t, J = 7.6 Hz, 1H), 6.81 (d, J = 8.0 Hz, 2H), 6.72 (t, J = 7.5 Hz, 1H), 6.03 – 5.83 
(m, 1H), 5.39 (s, 1H), 5.36 (d, J = 5.9 Hz, 1H), 4.74 (d, J = 8.1 Hz, 1H), 4.47 (s, 1H), 1.75 (s, 3H). 13C NMR (101 
MHz, CDCl3) δ = 144.1, 140.2, 137.3, 128.5, 127.8, 127.6, 126.7, 125.9, 123.3, 119.4, 119.0, 116.4, 85.5, 74.0, 31.9. 




Synthesized according to the general procedure for the addition of organolithium reagents to benzoxazine.  2a was 
treated with 1.1 eq of nBuLi at -78 °C and the reaction mixture was allowed to gradually warm to room temperature 
overnight. The product was obtained in 70% yield as a colorless oil. [α]20D = +262.0 (c 1.0, CHCl3). 1H NMR (400 
MHz, CDCl3) δ = 7.50 (d, J = 7.1 Hz, 2H), 7.32 (t, J = 7.3 Hz, 2H), 7.25 (t, J = 7.2 Hz, 1H), 7.10 (t, J = 7.6 Hz, 
1H), 6.80 (d, J = 8.2 Hz, 2H), 6.71 (t, J = 7.5 Hz, 1H), 5.94 (ddd, J = 11.3, 9.6, 8.1 Hz, 1H), 5.39 (d, J = 4.5 Hz, 
1H), 5.35 (s, 1H), 4.79 (d, J = 8.1 Hz, 1H), 4.48 (brs, 1H), 2.10 – 1.99 (m, 1H), 1.99 – 1.88 (m, 1H), 1.56 – 1.38 (m, 
1H), 1.38 – 1.23 (m, 2H), 1.22 – 1.09 (m, 1H), 0.87 (t, J = 7.3 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 143.5, 
140.3, 137.4, 128.4, 127.7, 127.5, 127.2, 125.9, 123.4, 119.1, 118.8, 116.3, 87.5, 73.7, 44.0, 25.4, 22.8, 13.9. HRMS 
(ESI+, m/z) calculated for C20H24NO3 [M + H]+ 294.1852; found 294.1854. 
 
                                                     




Synthesized according to the general procedure for the addition of organolithium reagents to benzoxazine.  2a was 
treated with 1.1 eq of n-hexylLi at -78 °C and the mixture was allowed to gradually warm to room temperature 
overnight. The product was obtained in 73% yield as a colorless oil. [α]20D = +166.7 (c 1.04, CHCl3). 1H NMR (400 
MHz, CDCl3) δ = 7.49 (d, J = 7.2 Hz, 2H), 7.31 (t, J = 7.3 Hz, 2H), 7.25 (t, J = 7.2 Hz, 1H), 7.10 (t, J = 7.3 Hz, 
1H), 6.81 (t, J = 8.5 Hz, 2H), 6.70 (t, J = 7.5 Hz, 1H), 6.01 – 5.80 (m, 1H), 5.38 (d, J = 4.5 Hz, 1H), 5.34 (s, 1H), 
4.78 (d, J = 8.0 Hz, 1H), 4.47 (brs, 1H), 2.02 (ddd, J = 13.7, 11.8, 5.0 Hz, 1H), 1.97 – 1.87 (m, 1H), 1.53 – 1.39 (m, 
1H), 1.37 – 1.02 (m, 7H), 0.85 (t, J = 6.8 Hz, 3H). 13C NMR (101 MHz, CDCl3) δ = 143.5, 140.3, 137.4, 128.4, 
127.7, 127.5, 127.2, 125.9, 123.4, 119.0, 118.8, 116.3, 87.5, 73.7, 44.2, 31.6, 29.4, 23.2, 22.5, 14.0. HRMS (ESI+, 




Synthesized according to the general procedure for the addition of organolithium reagents to benzoxazine.  2a was 
treated with 1.1 eq of tBuLi at -78 °C and the mixture was allowed to gradually warm to room temperature 
overnight. The product was obtained in 42% yield as a colorless oil. [α]20D = +89.4 (c 1.0, CHCl3). 1H NMR (400 
MHz, CDCl3) δ = 7.49 (d, J = 7.3 Hz, 2H), 7.30 (t, J = 7.3 Hz, 2H), 7.23 (t, J = 7.2 Hz, 1H), 7.05 (t, J = 7.6 Hz, 
1H), 6.79 (d, J = 7.6 Hz, 1H), 6.73 (d, J = 7.9 Hz, 1H), 6.64 (t, J = 7.4 Hz, 1H), 5.99 (ddd, J = 17.5, 10.1, 7.6 Hz, 
1H), 5.43 (dd, J = 17.1, 0.7 Hz, 1H), 5.35 (dd, J = 10.1, 1.5 Hz, 1H), 4.98 (d, J = 7.5 Hz, 1H), 4.74 (brs, 1H), 1.03 
(s, 9H). 13C NMR (101 MHz, CDCl3) δ = 140.8, 140.7, 137.7, 129.5, 127.5, 127.4, 127.3, 125.5, 123.0, 118.0, 117.8, 






To a solution of the 2a (40 mg, 0.17 mmol) in THF (2 mL) was added the MeLi·LiBr (0.51 mmol, 3.0 eq) at -40 °C. 
The mixture was allowed to gradually warm to RT. After stirring at RT for 3 h, the reaction was quenched with 
water (2 ml) and the mixture extracted with CH2Cl2 (3 x 5 mL). The combined organic layers were dried over 
Na2SO4 and concentrated under vacuum. The residue was purified by silica gel column chromatography 
(Pentane/EtOAc = 10:1) to yield 5 as colorless oil in 40% yield. 1H NMR (400 MHz, CHCl3) δ = 7.46 (d, J = 7.1 Hz, 
2H), 7.31 (t, J = 7.6 Hz, 2H), 7.21 (t, J = 7.3 Hz, 1H), 7.07 (dd, J = 7.5, 1.7 Hz, 1H), 6.86 (ddd, J = 8.2, 7.3, 1.7 Hz, 
1H), 6.56 (td, J = 7.4, 1.1 Hz, 1H), 6.27 (ddd, J = 17.2, 10.5, 4.9 Hz, 1H), 6.09 (d, J = 8.3 Hz, 1H), 5.47 (d, J = 
17.3 Hz, 1H), 5.35 (dt, J = 10.5, 1.6 Hz, 1H), 5.30 (d, J = 5.0 Hz, 1H), 1.65 (s, 3H), 1.64 (s, 3H). 13C NMR (101 
MHz, CHCl3) δ = 147.6, 144.6, 138.4, 128.5, 128.3, 128.2, 126.2, 125.6, 125.4, 115.9, 115.3, 115.2, 75.3, 55.6, 30.9, 
30.5.HRMS (ESI+, m/z) calculated for C18H22NO [M + H]+ 268.1689; found 268.1696. 
 
 







Crystal structure determination of 2m 
Crystal data. C16H12BrNO, Fw = 314.18, colourless plate, 0.21 x 0.10 x 0.09 mm3, triclinic, P1 (no. 1), a = 6.3154(5), 
b = 8.1371(7), c = 14.3362(12) Å,  = 85.222(3),  = 78.520(3),  = 70.043°, V = 678.53(10) Å3, Z = 2, Dx = 1.538 
g/cm3,  = 3.019 mm-1. 31603 Reflections were measured on a Bruker D8 Venture diffractometer with sealed tube 
and Triumph monochromator ( = 0.71073 Å) up to a resolution of (sin /)max = 0.64 Å-1 at a temperature of 293(2) 
K. Data collection and reduction was done using the Bruker software suite APEX2.[6] Intensity data were integrated 
with the SAINT V8.27B software.[4] Absorption correction and scaling was performed based on multiple measured 
reflections with SADABS (0.5697  0.7728 correction range).[4] 5756 Reflections were unique (Rint = 0.0311), of 
which 4785 were observed [I > 2(I)]. The structure was solved with Direct Methods using the program SHELXS-
97[5] and refined with SHELXL-97[7] against F2 of all reflections. All non-hydrogen atoms were refined with 
anisotropic displacement parameters. Hydrogen atoms were located in difference Fourier maps and refined with a 
riding model. 319 Parameters were refined with 17 restraints. R1/wR2 [I > 2(I)]: 0.0552 / 0.1339. R1/wR2 [all 
refl.]: 0.0675 / 0.1434. S = 1.046. Flack parameter[8] x = 0.007(11). Residual electron density between 0.27 and 
1.17 e/Å3. Geometry calculations and checking for higher symmetry was performed with the PLATON program.[9] 
 
Crystal structure determination of 4a 
Crystal data. C17H17NO, Fw = 251.32, colourless plate, 0.27 x 0.10 x 0.03 mm3, orthorhombic, P212121 (no. 19), a = 
8.2349(3), b = 12.5658(4), c = 12.9900(5) Å, V = 1344.18(8) Å3, Z = 4, Dx = 1.242 g/cm3,  = 0.077 mm-1. 55490 
Reflections were measured on a Bruker D8 Venture diffractometer with sealed tube and Triumph monochromator ( 
= 0.71073 Å) up to a resolution of (sin /)max = 0.64 Å-1 at a temperature of 100(2) K. Data collection and reduction 
was done using the Bruker software suite APEX2.[4] Intensity data were integrated with the SAINT V8.27B 
software.[4] Absorption correction and scaling was performed based on multiple measured reflections with SADABS 
(0.9796  0.9977 correction range). 2992 Reflections were unique (Rint = 0.0321), of which 2861 were observed [I > 
2(I)]. The structure was solved with Direct Methods using the program SHELXS-97[5] and refined with SHELXL-
97[5] against F2 of all reflections. All non-hydrogen atoms were refined with anisotropic displacement parameters. 
Hydrogen atoms were located in difference Fourier maps and refined with a riding model. 173 Parameters were 
refined with no restraints. R1/wR2 [I > 2(I)]: 0.0325 / 0.0820. R1/wR2 [all refl.]: 0.0347 / 0.836. S = 1.090. 
Residual electron density between 0.30 and 0.29 e/Å3. Geometry calculations and checking for higher symmetry 
was performed with the PLATON program.[7] 
                                                     
[6] Bruker, (2012). APEX2 (v2012.4-3), SAINT (Version 8.27B) and SADABS (Version 2012/1). Bruker AXS Inc., 
Madison, Wisconsin, USA. 
[7]G. M. Sheldrick, Acta Cryst. 2008, A64, 112. 
[8] H. D. Flack, Acta Cryst. 1983, A39, 876. 
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PDA Multi 1 290nm,4nm
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<Peak Table>
Peak#
 1 
 2 
Total
Ret. Time
 13,250 
 17,274 
Area
 9365003 
 9291971 
 18656974 
Height
 469565 
 330225 
 799790 
Conc.
 0,000 
 0,000 
Area%
 50,196 
 49,804 
 100,000 
N
H
Ph
O
4a
S62
